2 employees
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.
2017
$83K
from 2 investors over 2 rounds
SunRegen Healthcare AG raised undisclosed on March 8, 2019
Investors: GoBeyond
SunRegen Healthcare AG raised $83K on June 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)